mation. The results were compared to those of previous studies using other modalities. Results: A total of 294 scans from 146 fetuses from 15 +0 to 41 +6 weeks of gestation were included. Seven percent of scans were unanalysable and intraobserver variability was good (intraclass correlation coefficients for left and right ventricular mass 0.97 [0.87-0.99] and 0.99 [0.95-1.0], respectively). Mass and volume increased exponentially, showing good agreement with 3D mass estimates up to 28 weeks of gestation, after which our measurements were in better agreement with neonatal cardiac magnetic resonance imaging. There was good agreement with 4D volume estimates for the left ventricle. Conclusion: Current state-of-the-art 2D echocardiography platforms provide accurate, feasible, and reproducible fetal ventricular measures across gestation, and in certain circumstances may be the modality of choice.
Introduction
Two-dimensional (2D) echocardiography has for a long time been considered the modality of choice for fetal cardiovascular imaging in the clinical setting [1] . Congenital heart disease has a reported incidence of 6 per 1,000 live births for moderate to severe forms, which rises to 75 per 1,000 if more mild defects are included [2] . Structural and functional defects can often have an impact on fetal cardiac dimensions including ventricular mass. Furthermore, extracardiac factors, such as diaphragmatic hernias, and maternal conditions, for example diabetes, may also have an effect on fetal cardiac structure. Natural history data suggest that certain lesions progress with reduction in ventricular size whereas other lesions may result in progressive hypertrophy. Therefore, estimation of ventricular mass for screening and monitoring purposes can aid in assessing the severity and clinical course of the condition in order to guide counselling and plan perinatal care.
In recent years, newer modalities such as 3D and 4D sonography have emerged as potentially more accurate, optional adjuncts [1] . However, this has also led to parallel improvements in 2D technology, which has resulted in better image quality and development of offline quantification packages that offer a variety of automated measures. The purpose of our study was to evaluate stateof-the-art 2D echocardiography and quantification approaches for fetal echocardiography to assess their feasibility and reproducibility. As no 2D echocardiography reference ranges exist for fetal ventricular mass and volume, we also used the acquired data to report normal ranges in our cohort from 15 +0 to 41 +6 weeks of gestation. Finally, we compared the values obtained against other published results using newer modalities.
Subjects and Methods

Study Overview
We acquired echocardiographic datasets on fetuses between 15 +0 and 41 +6 weeks of gestation from uncomplicated control pregnancies who were taking part in a longitudinal study, Gestational age was calculated based on first-trimester ultrasound, and z-scores for birthweight were calculated using the international standard size at birth reference charts from the IN-TERGROWTH-21st Project [3, 4] using their online application (https://intergrowth21.tghn.org/global-perinatal-package/intergrowth-21st-comparison-application/).
Pregnancies were excluded if the offspring showed evidence of congenital cardiovascular disease, chromosomal abnormalities, or genetic disorders in the antenatal or postnatal period. The clinical records were also used to ensure that, for the purposes of development of fetal normal ranges, datasets from fetuses who went on to be delivered following any pregnancy complications, including intrauterine growth restriction, preterm birth (before 37 weeks of gestation), and/or exposure to chronic or new-onset maternal hypertension [5] , were excluded from analysis.
All mothers gave written informed consent in accordance with the Declaration of Helsinki and assent for involvement of their children, including permission to access maternal and offspring clinical records.
Echocardiography Image Acquisition
Each mother participated in between one and six fetal ultrasound scans during pregnancy. Fetuses were scanned using a Philips HD9 ultrasound system with a C6-3 curved-array transducer. During image acquisition, in a period of fetal quiescence, the fetal heart had to cover at least one-third of the screen using an apical or basal four-chamber view of the heart with the septum or free wall aligned parallel to the Doppler beam (plus or minus 10 degrees). Care was taken to visualise both atrioventricular valves opening and closing and the maximum diameter of both ventricles obtained. Absence of both maternal and fetal breathing and movements was also required. To enhance image resolution for postprocessing analysis, the frame rate was increased by minimising the sector width, the gains and depth were optimised, and multiple 7.5-s cine loops of the same four-chamber view were acquired to enable offline selection of the highest-quality loop. These were then retrospectively gated offline using TomTec Image Arena 4.6 where end diastole was defined at the point of mitral valve closure. Head circumference, abdominal circumference, and femur length were measured according to previously published protocols, with the average of three measurements being used [6] . Estimated fetal weight (EFW) was calculated using the Hadlock formula [7] .
Quantification of Ventricular Dimensions and Mass
Left and right end-diastolic volume (EDV) and ventricular mass were obtained by manual contouring of the endocardium and epicardium using TomTec Image Arena 4.6 from the apical four-chamber view. The end-diastolic frame was manually selected using the point of mitral valve closure as the marker. The contours were then manually set at the inner edge of the endocardium and the outer edge of the epicardium, but within the onset of the pericardium. Mass and volume were calculated by an algorithm built into the package which is equivalent to the single-plane Simpson's method (Fig. 1) . To maximise reproducibility, the entirety of the septum was contoured for both left and right ventricular (RV) measurements as in previous studies in this field [8, 9] . All datasets were analysed or the analysis directly supervised by one of the authors (C.Y.L.A.). Ten datasets were selected at random to assess the inter-and intraobserver variability in the measurement of left ventricular (LV) and RV mass (C.Y.L.A. and R.U.). LV to RV mass, and ventricular mass as a function of EFW (i.e., ventricular mass/EFW) according to gestational age were constructed using fractional polynomials. Where appropriate, we applied a multilevel, linear regression analysis to account for repeated measures [10] , but there were insignificant differences when compared to analyses that did not account for the hierarchy of the data. LV and RV mass, LV and RV EDV, ratio of LV to RV mass, and ventricular mass as a function of EFW exhibited a non-normal distribution; therefore, the data were log-transformed (natural log) to stabilise variance and transform the data to normality. Goodness-of-fit assessment incorporated a visual inspection of the quantile-quantile (q-q) plot of the residuals and a plot of fitted z-scores across gestational ages.
Statistical Analysis
Results
Characteristics of the Study Population
In total, 317 fetal echocardiograms from 146 eligible fetuses without pregnancy complications who were born at term were analysed. Twenty-three scans were unanalysable due to image quality, fetal position, or movement (7%), which left data from 294 scans to be used to build the nomograms. Ninety-one (62%) of the fetuses had one analysable echocardiogram, 44 (30%) had two, 18 (12%) had three, 10 (7%) had four, 3 (2%) had five, and 1 (0.7%) fetus had six. The range of gestational age at scan was 15 +0 to 41 +6 weeks. The cohort characteristics of the fetuses contributing to the nomograms are presented in Table 1 . Intraclass correlation coefficients with 95% confidence intervals for intra-and interobserver variability for measures of cardiac dimensions using TomTec Image Arena 4. 
Cardiac Mass and Volume
The normal ranges for LV and RV mass as well as EDV are displayed in Tables 2 and 3 and in Figure 2 with 3rd, 50th, and 97th centiles displayed. These show that both LV and RV mass as well as EDV increase exponentially through gestation. Values are presented as mean ± standard deviation or n (%), except for those of birth order, which are given as median ± interquartile range. 
Patterns of Mass Change
To investigate whether mass changes in proportion to cardiac volume in fetal circulation, we calculated trajectories for mass to EDV ratios for both ventricles. Mass to EDV ratios decreased slightly as pregnancy progressed, from 1.7 g/mL at 16 weeks to 1.3 g/mL at 40 weeks and from 1.7 g/mL to 1.1 g/mL for left and right ventricles, respectively (Fig. 3a) . We also studied ventricular dominance in utero and plotted RV to LV mass ratio, which increased through gestation from 0.81 at 16 weeks until term when mass in the two ventricles was equal (ratio of 1.0) (Fig. 3b) . Development of the fetal myocardium stayed in line with overall body growth, with the ratio of LV mass to EFW being 1 × 10 -3 at both 16 and 40 weeks and the ratio of RV mass to EFW being 0.8 × 10 -3 and 1.2 × 10 -3 (Fig. 3c ). Table 4 . Figure 4a shows trajectories reported in these papers for ventricular mass using 3D echo and real-time 3D echo [8, 11] overlaid on our 2D echo data. Real-time 3D echo generated values consistently greater than those of 3D echo by Bhat et al. [8] , but there was good to excellent agreement between 2D and 3D echo for both the LV and RV mass until 28 weeks of gestation.
Comparison could not be made with Messing et al. [12] for 4D ultrasound using spatiotemporal image correlation (STIC) with virtual organ computer-aided analysis as equations were not provided for mass.
Ventricular mass estimates are derived from subtracting intraventricular from total volume and multiplying the remainder by estimated fetal myocardial density (1.050 g/cm 3 ) [13] . We therefore compared volume estimates from our 2D data to those available using 4D echo from two other studies [12, 14] (Fig. 4b) . These figures show excellent agreement between 2D and 4D estimates for the left ventricle. Unfortunately, the published equation for the RV EDV in the study by Messing et al. [12] was incorrect and could not be plotted. The results from Hamill et al. [14] indicate an overestimation of RV volume by 2D methods.
Discussion
Normal ranges of fetal heart volumetry have been published in the past using 2D, 3D, and 4D methods [8, 12, [14] [15] [16] [17] [18] [19] [20] . They all demonstrate an increase in volume over gestation but with wide variation between studies, probably as a result of the use of different methodologies. However, there has been very little information published in the literature regarding estimates of mass.
Previous Studies
Previous postmortem and M-mode or 2D imaging studies have demonstrated that ventricular mass increases with gestational age and body weight [21] [22] [23] . We showed good agreement between 2D and 3D estimates of fetal ventricular mass up to 28 weeks of gestation, after which 3D estimates appear to generate values that are strikingly unrealistic, so that by 40 weeks the values are substantially greater than would be expected based on what is known about cardiac size after birth from neonatal echocardiography. This may be because estimated trajectories using real-time 3D were based on data from fetuses only up to 35 weeks of gestation, at which point the estimate for LV mass was 9.15 g compared to 6.07 g for 3D echo and our 2D estimate of 3.72 g [11] . Interestingly, our 2D measures at this time point are most consistent with a previous study looking at LV mass in preterm infants using cardiovascular magnetic resonance imaging, which is considered the gold standard imaging modality for quantification of ventricular mass in adults [24] . This study found that mean LV mass normalised to weight at scan at a mean corrected gestational age of 34 +6 weeks was 1.39 g/kg [25] . Bhat et al. [8] , using 3D echo, also only included fetuses up to 37 weeks of gestation, by which time estimated LV mass was lower at 8.24 g, but still substantially larger than the 4.31 g estimated by 2D echo.
There was an excellent agreement between 2D and 4D estimates for LV but not RV EDV [12, 14] . However, our fetal RV EDV estimates at 27 and 37 weeks were in good agreement with previously published measurements in preterm and term infants of similar gestations (1.26 vs. 1.8 mL at 27 weeks and 3.88 vs. 3.7 mL at 37 weeks for fetal and neonatal values, respectively) [26] .
Benefits of 2D Echocardiography
The benefits of using 2D ultrasound over more novel technologies are that it is simple, faster, cheaper, and more widely accessible, although the TomTec automated software may not be widely available, especially in lowincome settings. It is still seen as the primary imaging modality for fetal echocardiography, with other techniques seen as an optional adjunct [1] . In addition, newer techniques such as 3D ultrasound or 4D ultrasound using STIC require a significant learning period both for acquisition and analysis [8, 12, 14] . They also involve either manually defining the contours serially at each plane (4D with STIC) [12] or tracing along endocardial and epicardial surfaces (3D) [8] , both of which are significantly more time-consuming than extraction of data from 2D echocardiograms. There are limitations to newer methods, such as inability to perform measurements at extremes of gestation [12, 20] and reliance on the fetus being in a optimum position with a significant period of quiescence [12, 14, 20] as well as acoustic shadowing and dropout [14, 20] . This results in up to one-sixth of scans being unsuitable for analysis [8] . However, this is not an isolated problem with newer technologies; a previous study using the M-mode technique to describe ventricular geometry and function reported a rejection rate of 21%, much higher than the 7% in our study [27] . Finally, even though our acquisition was not gated, measurements could be timed for end diastole by offline gating Aye et al. using mitral valve closure, unlike 3D ultrasound where the four-chamber view can often only be analysed in mid diastole [8] .
Limitations 2D methods have previously been criticised as they have been shown to have a high level of interobserver variability compared to 3D and 4D methods, especially for the fetal right ventricle [8, 12] . We found, however, that using our newer quantification package for analysis, both inter-and in particular intraobserver variability were low. In addition, there was some variability in what was considered normal mass and volume from our 2D assessment throughout gestation, and it has been reported that in some cases of pathology, the use of 2D for volume measurements can underestimate the severity of the diagnosis [12] . However, this does not preclude using this modality as a screening tool where newer technologies are available, especially if serial measurements are taken by the same operator.
Another potential limitation of our study was that we did not provide validation against an inanimate or animal model for our measures of mass. This might have been useful as we were using a 2D single-plane method which may have resulted in inaccuracies due to geometrical assumptions. Single-plane methods using 2D ultrasound have previously been used in studies where estimation of volume and mass were technically challenging [28, 29] , such as the left atrium in adults demonstrating strong correlation with biplane measures [30] and the right ventricle in neonates [29] showing good agreement with angiography [31] . It is important to note that fetal echocardiography requires technical skill, and even then biplane views are not always feasible. Therefore, the requirement for only a four-chamber view, which can usually be visualised in the majority of fetuses by 13 weeks of gestation [32, 33] , makes this method for determination of mass widely applicable.
This study suggests that current state-of-the-art 2D echocardiography ultrasound platforms and offline analysis software provide accurate, feasible, and reproducible measures that allow estimation of fetal ventricular mass in a wide range of gestations and are likely to be of value across a range of healthcare settings. We have also reported, for the first time, fetal normal ranges of ventricular mass using 2D echo from our cohort between 15 +0 to 41 +6 weeks of gestation. We believe that in certain circumstances such as extremes of gestation, 2D ultrasound may be the modality of choice in the clinical setting, and at other times provide a screening or monitoring test, after which other novel modalities may be used as adjuncts.
